Company
NewAmsterdam Pharma Co N.V.
NAMS · CIK 0001936258
Purchase of 10,000 shares at $22.65 per share.
Reporting Person Davidson Michael H. · Officer Title Chief Executive Officer · Transaction Code P
Traded Sep 14, 2026 · Disclosed Sep 15, 2026
Source: SEC Form 4 · 0001193125-26-391985 · filed 2026-09-15 · View filing →
Sale of 1,600 shares at $25.32 per share.
Reporting Person Smither John W · Transaction Code S
Traded Sep 4, 2026 · Disclosed Sep 9, 2026
Source: SEC Form 4 · 0001193125-26-386508 · filed 2026-09-09 · View filing →
Acquisition (code A) of 3,200 shares at $0 per share.
Reporting Person Gunning Robert William · Officer Title Vice President, Controller · Transaction Code A
Traded Sep 1, 2026 · Disclosed Sep 3, 2026
Source: SEC Form 4 · 0001193125-26-381953 · filed 2026-09-03 · View filing →
Acquisition (code M) of 125,000 shares; price not stated (see filing).
Reporting Person Kastelein Johannes Jacob Pieter · Officer Title Chief Scientific Officer · Transaction Code M
Traded Aug 24, 2026 · Disclosed Aug 25, 2026
Source: SEC Form 4 · 0001193125-26-365202 · filed 2026-08-25 · View filing →
Sale of 125,000 shares at $26.91 per share.
Reporting Person Kastelein Johannes Jacob Pieter · Officer Title Chief Scientific Officer · Transaction Code S
Traded Aug 24, 2026 · Disclosed Aug 25, 2026
Source: SEC Form 4 · 0001193125-26-365202 · filed 2026-08-25 · View filing →